An independent enterprise with a business focus
The LDC is a subsidiary of Max Planck Innovation set up as a limited liability company (GmbH). Based on a sustainable financing concept, it will operate as a self-directed entity with an entrepreneurial approach, yet largely independent from the short-termed investment rules of capital markets.
Prepared to take on projects from various sources
The initial project portfolio will be sourced from Max Planck Institutes. However, we are open to collaborations with other public research organizations, academia or industry looking for professional drug discovery support to advance promising early-stage projects. All LDC projects will benefit from Max Planck Innovation's premier access to excellent researchers, industry experts, VC specialists and its track record in IP evaluation and technology transfer.
